GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jerusalem Pharmaceutical Co (XPAE:JPH) » Definitions » Net Interest Income

Jerusalem Pharmaceutical Co (XPAE:JPH) Net Interest Income : $-0.23 Mil (TTM As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Jerusalem Pharmaceutical Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Jerusalem Pharmaceutical Co's net interest income for the three months ended in Sep. 2024 was $-0.08 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.23 Mil.


Jerusalem Pharmaceutical Co Net Interest Income Historical Data

The historical data trend for Jerusalem Pharmaceutical Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jerusalem Pharmaceutical Co Net Interest Income Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.28 - - -

Jerusalem Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 - -0.08 -0.06 -0.08

Jerusalem Pharmaceutical Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jerusalem Pharmaceutical Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Jerusalem Pharmaceutical Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Jerusalem Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.

Jerusalem Pharmaceutical Co Headlines

No Headlines